K. Oosterhuis

发表

Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro.

M. Rots, J. Schouten, P. Limburg, 2005, American journal of physiology. Cell physiology.

Transposon leads to contamination of clinical pDNA vaccine.

T. Schumacher, J. Beijnen, J. Haanen, 2013, Vaccine.

Functional inhibition of NF-kappa B signal transduction in alpha v alpha beta 3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant I kappa B

M. Rots, C. Trautwein, B. Kroesen, 2018 .

University of Groningen Functional inhibition of NF-kappa B signal transduction in alpha v alpha beta 3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant I kappa B gene Ogawara,

M. Rots, C. Trautwein, B. Kroesen, 2015 .

Functional inhibition of NF-κB signal transduction in αvβ3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IκB gene

M. Rots, C. Trautwein, B. Kroesen, 2006, Arthritis research & therapy.

Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines

T. Schumacher, J. Haanen, K. Oosterhuis, 2015, Gene Therapy.

Preclinical development of DNA vaccine candidates for the treatment of HPV16 induced malignancies

K. Oosterhuis, 2012 .

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control

J. van Bergen, K. Oosterhuis, F. Ossendorp, 2019, Oncoimmunology.

Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.

J. Engbersen, T. Schumacher, J. Beijnen, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α- and IL-1β-induced proinflammatory status of endothelial cells in vitro

M. Rots, J. Schouten, P. Limburg, 2005 .

Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease

E. Bunnik, H. Schuitemaker, K. Oosterhuis, 2017, International journal of cancer.

Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination.

J. van Bergen, K. Oosterhuis, Iris Zoutendijk, 2022, Vaccine.

DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms.

J. Beijnen, J. Haanen, K. Oosterhuis, 2009, Journal of controlled release : official journal of the Controlled Release Society.

DNA vaccines and intradermal vaccination by DNA tattooing.

T. Schumacher, J. Haanen, K. Oosterhuis, 2012, Current topics in microbiology and immunology.

Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses.

H. Schuitemaker, K. Oosterhuis, Taco G. Uil, 2018, Vaccine.

Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.

T. Schumacher, J. Haanen, K. Oosterhuis, 2012, Human gene therapy.

RATIONAL DESIGN OF DNA VACCINES FOR THE INDUCTION OF HPV16 E6 AND E7 SPECIFIC CYTOTOXIC T CELL RESPONSES

T. Schumacher, J. Haanen, K. Oosterhuis, 2012 .

Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7

T. Schumacher, J. Haanen, K. Oosterhuis, 2011, International journal of cancer.

Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.

J. Haanen, K. Oosterhuis, E. Hooijberg, 2012, Vaccine.

Intradermal vaccination by DNA tattooing.

T. Schumacher, J. Haanen, K. Oosterhuis, 2014, Methods in molecular biology.

Recent advances towards the clinical application of DNA vaccines.

J. Haanen, K. Oosterhuis, A. Bins, 2013, The Netherlands journal of medicine.

DNA vaccination in oncology: current status, opportunities and perspectives.

J. Beijnen, J. Haanen, K. Oosterhuis, 2010, Current clinical pharmacology.